Biolabssss

Creative Biolabs is highly specialized in advanced antibody biochemistry and engineering. With more than a decade of exploration and expansion, our current research and service capacity covers the entire new drug discovery and development pipeline, ranging from early discovery, pre-clinical evaluations, cGMP manufacturing, to clinical trials.

Creative Biolabs is highly specialized in advanced antibody biochemistry and engineering. With more than a decade of exploration and expansion, our current research and service capacity covers the entire new drug discovery and development pipeline, ranging from early discovery, pre-clinical evaluations, cGMP manufacturing, to clinical trials.

The path of discovery of each therapeutic antibody is different. We focus on your antibody goals and work with you to achieve the ADCC/CDC enhancement goals. Whether you need expression optimization, recombinant protein production, antibody ADCC/CDC modification design, or cell line development, Creative Biolabs provides solutions to drive your research and accelerate your market.

The path of discovery of each therapeutic antibody is different. We focus on your antibody goals and work with you to achieve the ADCC/CDC enhancement goals. Whether you need expression optimization, recombinant protein production, antibody ADCC/CDC modification design, or cell line development, Creative Biolabs provides solutions to drive your research and accelerate your market.

Creative Biolabs has been dedicated to providing high-quality services in academic and life science worldwide. In the past decade, we have become a leader in discovering and manufacturing recombinant antibodies.

Creative Biolabs possesses unchallenged experience in synthesis of tetravalent heavy chain-only antibodies (hcAbs). Multiple platforms of Creative Biolabs are elaborately integrated for providing customer an expected tetravalent hcAb with high affinity and low immunogenicity for both academic and clinical purposes.

Creative Biolabs is an undisputed global leader in the rapidly emerging market of bispecific antibodies (BsAbs). Based on the well-established BsAbs production platform, we offer a full range of high quality BsAbs, including the trifunctional hybrid antibodies (Triomab).

As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs has won good reputation among our worldwide customers for successfully accomplishing numerous challenging projects including generation of many functional membrane proteins.

As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs has won good reputation among our worldwide customers for successfully accomplishing numerous challenging projects including generation of many functional membrane proteins.

Creative Biolabs is a leading global biologics company established in the United States. With more than a decade of exploration and expansion, Creative Biolabs offers comprehensive one-stop services for Complement Therapeutics. Our project procedure can be totally designed to meet your special requirements. We will be your best partner in Complement-based Drug Discovery.

Creative Biolabs is a leading global biologics company established in the United States. With more than a decade of exploration and expansion, Creative Biolabs offers comprehensive one-stop services for Complement Therapeutics. Our project procedure can be totally designed to meet your special requirements. We will be your best partner in Complement-based Drug Discovery.

nanoparticle tracking analysis exosome from Creative Biolabs. Supported by in-house scientists and first-in-class technological platform, Creative Biolabs is confident in providing the best and comprehensive services covering exosome sampling, analysis, manufacturing, and exosome-based application.

Creative Biolabs, specialized in exosome research, is a world-leading services provider of exosome-related services. Our scientists with years of experience in exosome research have established a powerful and versatile technical platform, which allows us to offer comprehensive exosome-related services for customers all over the world. Please contact our technical services to discuss your project and create a custom quote.

Creative Biolabs focuses on studying the role of γδ T cell in the progression of cancer and discovering new γδ T cell based therapies for cancer. We integrate deep-rooted biological expertise with our comprehensive γδ T profiling and development technologies to rapidly discover and advance a pipeline of γδ T cell based therapy to treat cancer.

Cellular immunity mediated by T lymphocytes plays a central role in both initiate and adaptive immune responses. There are multiple subgroups of T lymphocytes, which are categorized into αβ T cells and γδ T cells distinguished by the expression of the featured αβ or γδ T cell receptor (TCR) on the cell surface. The common αβ T cells and special γδ T cells originate from a common progenitor in the thymus but are fundamentally different in surface markers, distributions, antigen recognition, and functions, both of which coordinate and cooperate to induce a diversity of immune responses against

Therapeutic glycoproteins have become the fastest growing fields in the pharmaceutical industry. Creative Biolabs is a leading customer service provider in the field of therapeutic glycoprotein development. Equipped with the latest world-leading technology platforms and professional scientific staff, Creative Biolabs is dedicated to providing high-quality glycoprotein production and corresponding analysis service. Our seasoned scientists are more than happy to share our cutting-edge experience in therapeutic glycoprotein development to meet every unique requirement of our clients.

Therapeutic glycoproteins have become the fastest growing fields in the pharmaceutical industry. Creative Biolabs is a leading customer service provider in the field of therapeutic glycoprotein development. Equipped with the latest world-leading technology platforms and professional scientific staff, Creative Biolabs is dedicated to providing high-quality glycoprotein production and corresponding analysis service. Our seasoned scientists are more than happy to share our cutting-edge experience in therapeutic glycoprotein development to meet every unique requirement of our clients.

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow treating a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery. There are numerous ongoing researches of which the focus is testing several approaches to gene therapy. Although gene therapy is a promising treatment scenario for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections, there is still a number of obstacles to be overcome in terms of the therapeutic modality selection and de

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow treating a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery. There are numerous ongoing researches of which the focus is testing several approaches to gene therapy. Although gene therapy is a promising treatment scenario for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections, there is still a number of obstacles to be overcome in terms of the therapeutic modality selection and de

4-1BB, also known as CD137 or TNFRS9, belongs to the tumor necrosis factor (TNF) receptor family, including multiple T cells co-stimulatory receptors, such as CD40, CD27, GITR, HVEM, and LIGHT. 4-1BB is expressed on a wide variety of cell types, including activated T cells, natural killer (NK) cells, dendritic cells (DCs), gamma-delta T cells, B cells, monocytes, and neutrophils. Its ligand, 4-1BBL, is localized to dendritic cells.